Cite
HARVARD Citation
Chen, G. et al. (2020). Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma. Epigenetics. 15 (6), pp. 684-701. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, G. et al. (2020). Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma. Epigenetics. 15 (6), pp. 684-701. [Online].